Showing results (271-280 of 297) with videos related to

Sort By:
Pageof 30
British Medical Journal (Clinical Research Ed.)|August 29, 1987
Cardiovascular effects of training for a marathon run in unfit middle aged menI N Findlay, R S Taylor, H J Dargie, et al.
Circulation|April 13, 1999
Gender differences in survival in advanced heart failure. Insights from the FIRST studyK F Adams, C A Sueta, M Gheorghiade, et al.
The Journal of Surgical Research|March 24, 2000
Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasiaJ E Fortunato, H J Mauceri, H Kocharyan, et al.
European Heart Journal|September 1, 1996
Mode of death in chronic heart failure. A request and proposition for more accurate classificationR Narang, J G Cleland, L Erhardt, et al.
Heart (British Cardiac Society)|September 6, 2006
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programmeN M Hawkins, D Wang, J J V McMurray, et al.
The American Journal of Cardiology|May 1, 1983
Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarctionJ Herlitz, D Elmfeldt, A Hjalmarson, et al.
American Heart Journal|July 1, 1999
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST)C M O'Connor, W A Gattis, B F Uretsky, et al.
Lancet (London, England)|October 17, 1981
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trialA Hjalmarson, D Elmfeldt, J Herlitz, et al.
Clinical Cardiology|May 22, 1998
Management strategies for a better outcome in unstable coronary artery diseaseR W Campbell, L Wallentin, F W Verheugt, et al.
Pharmacological Research|June 6, 2022
Pragmatic diagnostic and therapeutic algorithms to optimize new potassium binder use in cardiorenal diseaseP Rossignol, J Silva-Cardoso, M N Kosiborod, et al.
Pageof 30